
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of principal executive offices and Zip Code) | ||
( | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 2.05. | Costs Associated with Exit or Disposal Activities. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | ||||||||||
| 99.1 | |||||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | By: | /s/ Mark Murphy | |||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Farhan Ahmad | Erica Rodriguez Pompen | ||||||
| Investor Relations | Media Relations | |||||||
| [email protected] | [email protected] | |||||||
| (408) 834-1927 | (408) 834-1873 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
| FQ1-23 | FQ4-22 | FQ1-22 | FQ1-23 | FQ4-22 | FQ1-22 | ||||||||||||||||||
| Revenue | $ | 4,085 | $ | 6,643 | $ | 7,687 | $ | 4,085 | $ | 6,643 | $ | 7,687 | |||||||||||
| Gross margin | 893 | 2,622 | 3,565 | 934 | 2,676 | 3,616 | |||||||||||||||||
| percent of revenue | 21.9 | % | 39.5 | % | 46.4 | % | 22.9 | % | 40.3 | % | 47.0 | % | |||||||||||
| Operating expenses | 1,102 | 1,101 | 934 | 999 | 1,014 | 891 | |||||||||||||||||
| Operating income (loss) | (209) | 1,521 | 2,631 | (65) | 1,662 | 2,725 | |||||||||||||||||
| percent of revenue | (5.1 | %) | 22.9 | % | 34.2 | % | (1.6 | %) | 25.0 | % | 35.4 | % | |||||||||||
| Net income (loss) | (195) | 1,492 | 2,306 | (39) | 1,621 | 2,471 | |||||||||||||||||
| Diluted earnings (loss) per share | (0.18) | 1.35 | 2.04 | (0.04) | 1.45 | 2.16 | |||||||||||||||||
| FQ2-23 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $3.80 billion ± $200 million | $3.80 billion ± $200 million | ||||||
Gross margin | 7.5% ± 2.5% | 8.5% ± 2.5% | ||||||
Operating expenses | $1.08 billion ± $15 million | $945 million ± $15 million | ||||||
Diluted earnings (loss) per share | ($0.79) ± $0.10 | ($0.62) ± $0.10 | ||||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| December 1, 2022 | September 1, 2022 | December 2, 2021 | |||||||||
| Revenue | $ | 4,085 | $ | 6,643 | $ | 7,687 | |||||
| Cost of goods sold | 3,192 | 4,021 | 4,122 | ||||||||
| Gross margin | 893 | 2,622 | 3,565 | ||||||||
| Research and development | 849 | 839 | 712 | ||||||||
| Selling, general, and administrative | 251 | 280 | 259 | ||||||||
| Restructure and asset impairments | 13 | 5 | 38 | ||||||||
| Other operating (income) expense, net | (11) | (23) | (75) | ||||||||
| Operating income (loss) | (209) | 1,521 | 2,631 | ||||||||
| Interest income | 88 | 54 | 10 | ||||||||
| Interest expense | (51) | (45) | (45) | ||||||||
| Other non-operating income (expense), net | (4) | 23 | (75) | ||||||||
| (176) | 1,553 | 2,521 | |||||||||
| Income tax (provision) benefit | (8) | (56) | (219) | ||||||||
| Equity in net income (loss) of equity method investees | (11) | (5) | 4 | ||||||||
| Net income (loss) | $ | (195) | $ | 1,492 | $ | 2,306 | |||||
| Earnings (loss) per share | |||||||||||
| Basic | $ | (0.18) | $ | 1.36 | $ | 2.06 | |||||
| Diluted | (0.18) | 1.35 | 2.04 | ||||||||
| Number of shares used in per share calculations | |||||||||||
| Basic | 1,090 | 1,097 | 1,119 | ||||||||
| Diluted | 1,090 | 1,106 | 1,130 | ||||||||
| As of | December 1, 2022 | September 1, 2022 | ||||||
| Assets | ||||||||
| Cash and equivalents | $ | 9,574 | $ | 8,262 | ||||
| Short-term investments | 1,007 | 1,069 | ||||||
| Receivables | 3,318 | 5,130 | ||||||
| Inventories | 8,359 | 6,663 | ||||||
| Other current assets | 663 | 657 | ||||||
| Total current assets | 22,921 | 21,781 | ||||||
| Long-term marketable investments | 1,426 | 1,647 | ||||||
| Property, plant, and equipment | 39,335 | 38,549 | ||||||
| Operating lease right-of-use assets | 693 | 678 | ||||||
| Intangible assets | 428 | 421 | ||||||
| Deferred tax assets | 672 | 702 | ||||||
| Goodwill | 1,228 | 1,228 | ||||||
| Other noncurrent assets | 1,171 | 1,277 | ||||||
| Total assets | $ | 67,874 | $ | 66,283 | ||||
| Liabilities and equity | ||||||||
| Accounts payable and accrued expenses | $ | 5,438 | $ | 6,090 | ||||
| Current debt | 171 | 103 | ||||||
| Other current liabilities | 916 | 1,346 | ||||||
| Total current liabilities | 6,525 | 7,539 | ||||||
| Long-term debt | 10,094 | 6,803 | ||||||
| Noncurrent operating lease liabilities | 625 | 610 | ||||||
| Noncurrent unearned government incentives | 516 | 589 | ||||||
| Other noncurrent liabilities | 808 | 835 | ||||||
| Total liabilities | 18,568 | 16,376 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders’ equity | ||||||||
| Common stock | 123 | 123 | ||||||
| Additional capital | 10,335 | 10,197 | ||||||
| Retained earnings | 46,873 | 47,274 | ||||||
| Treasury stock | (7,552) | (7,127) | ||||||
| Accumulated other comprehensive income (loss) | (473) | (560) | ||||||
| Total equity | 49,306 | 49,907 | ||||||
| Total liabilities and equity | $ | 67,874 | $ | 66,283 | ||||
| For the three months ended | December 1, 2022 | December 2, 2021 | ||||||
| Cash flows from operating activities | ||||||||
| Net income (loss) | $ | (195) | $ | 2,306 | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation expense and amortization of intangible assets | 1,921 | 1,671 | ||||||
| Stock-based compensation | 146 | 118 | ||||||
| (Gain) loss on debt repurchases | — | 83 | ||||||
Change in operating assets and liabilities: | ||||||||
| Receivables | 1,842 | 67 | ||||||
| Inventories | (1,697) | (344) | ||||||
| Accounts payable and accrued expenses | (1,056) | (42) | ||||||
| Other | (18) | 79 | ||||||
| Net cash provided by operating activities | 943 | 3,938 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (2,449) | (3,265) | ||||||
| Purchases of available-for-sale securities | (90) | (528) | ||||||
| Proceeds from maturities of available-for-sale securities | 358 | 313 | ||||||
| Proceeds from sales of available-for-sale securities | 4 | 124 | ||||||
| Proceeds from government incentives | 2 | 55 | ||||||
| Proceeds from sale of Lehi, Utah fab | — | 893 | ||||||
| Other | (91) | (77) | ||||||
| Net cash provided by (used for) investing activities | (2,266) | (2,485) | ||||||
| Cash flows from financing activities | ||||||||
| Proceeds from issuance of debt | 3,349 | 2,000 | ||||||
| Repurchases of common stock - repurchase program | (425) | (259) | ||||||
| Payments of dividends to shareholders | (126) | (112) | ||||||
| Payments on equipment purchase contracts | (47) | (78) | ||||||
| Repayments of debt | (20) | (1,949) | ||||||
| Other | (99) | (115) | ||||||
| Net cash provided by (used for) financing activities | 2,632 | (513) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | (6) | (6) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 1,303 | 934 | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 8,339 | 7,829 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 9,642 | $ | 8,763 | ||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| December 1, 2022 | September 1, 2022 | December 2, 2021 | |||||||||
| GAAP gross margin | $ | 893 | $ | 2,622 | $ | 3,565 | |||||
| Stock-based compensation | 36 | 49 | 43 | ||||||||
| Other | 5 | 5 | 8 | ||||||||
| Non-GAAP gross margin | $ | 934 | $ | 2,676 | $ | 3,616 | |||||
| GAAP operating expenses | $ | 1,102 | $ | 1,101 | $ | 934 | |||||
| Stock-based compensation | (90) | (82) | (73) | ||||||||
| Restructure and asset impairments | (13) | (5) | (38) | ||||||||
| Other | — | — | 68 | ||||||||
| Non-GAAP operating expenses | $ | 999 | $ | 1,014 | $ | 891 | |||||
| GAAP operating income (loss) | $ | (209) | $ | 1,521 | $ | 2,631 | |||||
| Stock-based compensation | 126 | 131 | 116 | ||||||||
| Restructure and asset impairments | 13 | 5 | 38 | ||||||||
| Other | 5 | 5 | (60) | ||||||||
| Non-GAAP operating income (loss) | $ | (65) | $ | 1,662 | $ | 2,725 | |||||
GAAP net income (loss) | $ | (195) | $ | 1,492 | $ | 2,306 | |||||
| Stock-based compensation | 126 | 131 | 116 | ||||||||
| Restructure and asset impairments | 13 | 5 | 38 | ||||||||
| Amortization of debt discount and other costs | 5 | 6 | 9 | ||||||||
| (Gain) loss on debt repurchases | — | — | 83 | ||||||||
| Other | 5 | 5 | (60) | ||||||||
Estimated tax effects of above and other tax adjustments | 7 | (18) | (21) | ||||||||
| Non-GAAP net income (loss) | $ | (39) | $ | 1,621 | $ | 2,471 | |||||
GAAP weighted-average common shares outstanding - Diluted | 1,090 | 1,106 | 1,130 | ||||||||
Adjustment for stock-based compensation | — | 15 | 11 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted | 1,090 | 1,121 | 1,141 | ||||||||
GAAP diluted earnings (loss) per share | $ | (0.18) | $ | 1.35 | $ | 2.04 | |||||
Effects of the above adjustments | 0.14 | 0.10 | 0.12 | ||||||||
Non-GAAP diluted earnings (loss) per share | $ | (0.04) | $ | 1.45 | $ | 2.16 | |||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| December 1, 2022 | September 1, 2022 | December 2, 2021 | |||||||||
GAAP net cash provided by operating activities | $ | 943 | $ | 3,777 | $ | 3,938 | |||||
Expenditures for property, plant, and equipment | (2,449) | (3,613) | (3,265) | ||||||||
| Proceeds from sales of property, plant, and equipment | 23 | 30 | 21 | ||||||||
Payments on equipment purchase contracts | (47) | (9) | (78) | ||||||||
Amounts funded by partners | 2 | 11 | 55 | ||||||||
| Investments in capital expenditures, net | (2,471) | (3,581) | (3,267) | ||||||||
Adjusted free cash flow | $ | (1,528) | $ | 196 | $ | 671 | |||||
| As of | December 1, 2022 | September 1, 2022 | December 2, 2021 | ||||||||
Cash and short-term investments | $ | 10,581 | $ | 9,331 | $ | 9,580 | |||||
Current and noncurrent restricted cash | 68 | 77 | 83 | ||||||||
Long-term marketable investments | 1,426 | 1,647 | 1,817 | ||||||||
Current and long-term debt | (10,265) | (6,906) | (7,022) | ||||||||
Net cash | $ | 1,810 | $ | 4,149 | $ | 4,458 | |||||
| FQ2-23 | GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue | $3.80 billion ± $200 million | — | $3.80 billion ± $200 million | ||||||||||||||||||||
Gross margin | 7.5% ± 2.5% | ~1% | A | 8.5% ± 2.5% | |||||||||||||||||||
Operating expenses | $1.08 billion ± $15 million | $137 million | B | $945 million ± $15 million | |||||||||||||||||||
Diluted earnings (loss) per share(1) | ($0.79) ± $0.10 | $0.17 | A, B, C | ($0.62) ± $0.10 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | $ | 40 | ||||||||||||||||||||
A | Other – cost of goods sold | 4 | |||||||||||||||||||||
B | Stock-based compensation – research and development | 62 | |||||||||||||||||||||
B | Stock-based compensation – selling, general, and administrative | 45 | |||||||||||||||||||||
| B | Restructure and asset impairments | 30 | |||||||||||||||||||||
C | Tax effects of the above items and other tax adjustments | 8 | |||||||||||||||||||||
| $ | 189 | ||||||||||||||||||||||